Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Corrigendum to "Considerations and quality controls when analyzing cell-free tumor DNA" [Biomol. Detect. Quantif. 17 (2019) 100078].

Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A.

Biomol Detect Quantif. 2019 Jun 18;17:100091. doi: 10.1016/j.bdq.2019.100091. eCollection 2019 Mar.

2.

Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma.

Zhou Z, Kalatskaya I, Russell D, Marcon N, Cirocco M, Krzyzanowski PM, Streutker C, Liang H, Litle VR, Godfrey TE, Stein L.

Clin Exp Gastroenterol. 2019 May 15;12:219-229. doi: 10.2147/CEG.S186958. eCollection 2019.

3.

The Molecular Biologic Basis of Esophageal and Gastric Cancers.

Pennathur A, Godfrey TE, Luketich JD.

Surg Clin North Am. 2019 Jun;99(3):403-418. doi: 10.1016/j.suc.2019.02.010. Review.

PMID:
31047032
4.

Considerations and quality controls when analyzing cell-free tumor DNA.

Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A.

Biomol Detect Quantif. 2019 Feb 13;17:100078. doi: 10.1016/j.bdq.2018.12.003. eCollection 2019 Mar. Erratum in: Biomol Detect Quantif. 2019 Jun 18;17:100091.

5.

Impact of Polymerase Fidelity on Background Error Rates in Next-Generation Sequencing with Unique Molecular Identifiers/Barcodes.

Filges S, Yamada E, Ståhlberg A, Godfrey TE.

Sci Rep. 2019 Mar 5;9(1):3503. doi: 10.1038/s41598-019-39762-6.

6.

Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.

Egyud M, Sridhar P, Devaiah A, Yamada E, Saunders S, Ståhlberg A, Filges S, Krzyzanowski PM, Kalatskaya I, Jiao W, Stein LD, Jalisi S, Godfrey TE.

Head Neck. 2019 May;41(5):1351-1358. doi: 10.1002/hed.25563. Epub 2018 Dec 15.

7.

miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.

Muñoz-Largacha JA, Gower AC, Sridhar P, Deshpande A, O'Hara CJ, Yamada E, Godfrey TE, Fernando HC, Litle VR.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):714-727. doi: 10.1016/j.jtcvs.2017.02.071. Epub 2017 Apr 12.

8.

Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing.

Ståhlberg A, Krzyzanowski PM, Egyud M, Filges S, Stein L, Godfrey TE.

Nat Protoc. 2017 Apr;12(4):664-682. doi: 10.1038/nprot.2017.006. Epub 2017 Mar 2.

PMID:
28253235
9.

Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences.

Pang C, LaLonde A, Godfrey TE, Que J, Sun J, Wu TT, Zhou Z.

Clin Exp Gastroenterol. 2017 Feb 7;10:29-37. doi: 10.2147/CEG.S117842. eCollection 2017.

10.

Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing.

Ståhlberg A, Krzyzanowski PM, Jackson JB, Egyud M, Stein L, Godfrey TE.

Nucleic Acids Res. 2016 Jun 20;44(11):e105. doi: 10.1093/nar/gkw224. Epub 2016 Apr 7.

11.

Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR.

Jackson JB, Choi DS, Luketich JD, Pennathur A, Ståhlberg A, Godfrey TE.

J Mol Diagn. 2016 Mar;18(2):235-43. doi: 10.1016/j.jmoldx.2015.10.004. Epub 2016 Jan 2.

12.

Bile Salts at Low pH Cause Dilation of Intercellular Spaces in In Vitro Stratified Primary Esophageal Cells, Possibly by Modulating Wnt Signaling.

Ghatak S, Reveiller M, Toia L, Ivanov AI, Zhou Z, Redmond EM, Godfrey TE, Peters JH.

J Gastrointest Surg. 2016 Mar;20(3):500-9. doi: 10.1007/s11605-015-3062-2. Epub 2015 Dec 29.

PMID:
26715559
13.

Properties of targeted preamplification in DNA and cDNA quantification.

Andersson D, Akrap N, Svec D, Godfrey TE, Kubista M, Landberg G, Ståhlberg A.

Expert Rev Mol Diagn. 2015;15(8):1085-100. doi: 10.1586/14737159.2015.1057124. Epub 2015 Jul 1.

14.

Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference.

Zhou Z, Xia Y, Bandla S, Zakharov V, Wu S, Peters J, Godfrey TE, Sun J.

Hum Pathol. 2014 Aug;45(8):1744-51. doi: 10.1016/j.humpath.2014.02.029. Epub 2014 May 15.

PMID:
24951052
15.

Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies.

Zhou Z, Bandla S, Ye J, Xia Y, Que J, Luketich JD, Pennathur A, Peters JH, Tan D, Godfrey TE.

BMC Gastroenterol. 2014 Apr 17;14:78. doi: 10.1186/1471-230X-14-78.

16.

Comparison of cancer-associated genetic abnormalities in columnar-lined esophagus tissues with and without goblet cells.

Bandla S, Peters JH, Ruff D, Chen SM, Li CY, Song K, Thoms K, Litle VR, Watson T, Chapurin N, Lada M, Pennathur A, Luketich JD, Peterson D, Dulak A, Lin L, Bass A, Beer DG, Godfrey TE, Zhou Z.

Ann Surg. 2014 Jul;260(1):72-80. doi: 10.1097/SLA.0000000000000424.

17.

Bile acid at low pH reduces squamous differentiation and activates EGFR signaling in esophageal squamous cells in 3-D culture.

Ghatak S, Reveiller M, Toia L, Ivanov A, Godfrey TE, Peters JH.

J Gastrointest Surg. 2013 Oct;17(10):1723-31. doi: 10.1007/s11605-013-2287-1. Epub 2013 Aug 7.

PMID:
23921815
18.

Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer.

Trivedi S, Mattos J, Gooding W, Godfrey TE, Ferris RL.

Otolaryngol Head Neck Surg. 2013 Aug;149(2):261-8. doi: 10.1177/0194599813486876. Epub 2013 Apr 26.

PMID:
23625795
19.

Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, Bandla S, Imamura Y, Schumacher SE, Shefler E, McKenna A, Carter SL, Cibulskis K, Sivachenko A, Saksena G, Voet D, Ramos AH, Auclair D, Thompson K, Sougnez C, Onofrio RC, Guiducci C, Beroukhim R, Zhou Z, Lin L, Lin J, Reddy R, Chang A, Landrenau R, Pennathur A, Ogino S, Luketich JD, Golub TR, Gabriel SB, Lander ES, Beer DG, Godfrey TE, Getz G, Bass AJ.

Nat Genet. 2013 May;45(5):478-86. doi: 10.1038/ng.2591. Epub 2013 Mar 24.

20.

Gene expression profiles in esophageal adenocarcinoma predict survival after resection.

Pennathur A, Xi L, Litle VR, Gooding WE, Krasinskas A, Landreneau RJ, Godfrey TE, Luketich JD.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):505-12; discussion 512-3. doi: 10.1016/j.jtcvs.2012.10.031.

21.

Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma.

Choy B, Bandla S, Xia Y, Tan D, Pennathur A, Luketich JD, Godfrey TE, Peters JH, Sun J, Zhou Z.

BMC Gastroenterol. 2012 Oct 18;12:146. doi: 10.1186/1471-230X-12-146.

22.

Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.

Dulak AM, Schumacher SE, van Lieshout J, Imamura Y, Fox C, Shim B, Ramos AH, Saksena G, Baca SC, Baselga J, Tabernero J, Barretina J, Enzinger PC, Corso G, Roviello F, Lin L, Bandla S, Luketich JD, Pennathur A, Meyerson M, Ogino S, Shivdasani RA, Beer DG, Godfrey TE, Beroukhim R, Bass AJ.

Cancer Res. 2012 Sep 1;72(17):4383-93. Epub 2012 Jul 2.

23.

Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells.

Reveiller M, Ghatak S, Toia L, Kalatskaya I, Stein L, D'Souza M, Zhou Z, Bandla S, Gooding WE, Godfrey TE, Peters JH.

Ann Surg. 2012 Jun;255(6):1113-20. doi: 10.1097/SLA.0b013e3182512af9.

PMID:
22498892
24.

Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma.

Bandla S, Pennathur A, Luketich JD, Beer DG, Lin L, Bass AJ, Godfrey TE, Litle VR.

Ann Thorac Surg. 2012 Apr;93(4):1101-6. doi: 10.1016/j.athoracsur.2012.01.064. Erratum in: Ann Thorac Surg. 2012 Sep;94(3):1042.

25.

Rapid molecular detection of metastatic head and neck squamous cell carcinoma as an intraoperative adjunct to sentinel lymph node biopsy.

Ferris RL, Stefanika P, Xi L, Gooding W, Seethala RR, Godfrey TE.

Laryngoscope. 2012 May;122(5):1020-30. doi: 10.1002/lary.22467. Epub 2012 Mar 23.

26.

Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation.

Barry CT, D'Souza M, McCall M, Safadjou S, Ryan C, Kashyap R, Marroquin C, Orloff M, Almudevar A, Godfrey TE.

Am J Transplant. 2012 Feb;12(2):428-37. doi: 10.1111/j.1600-6143.2011.03788.x. Epub 2011 Oct 18.

27.

Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.

Ismail A, Bandla S, Reveiller M, Toia L, Zhou Z, Gooding WE, Kalatskaya I, Stein L, D'Souza M, Litle VR, Peters JH, Pennathur A, Luketich JD, Godfrey TE.

Clin Cancer Res. 2011 Jul 1;17(13):4513-22. doi: 10.1158/1078-0432.CCR-11-0244. Epub 2011 May 18.

28.

HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma.

Hu Y, Bandla S, Godfrey TE, Tan D, Luketich JD, Pennathur A, Qiu X, Hicks DG, Peters JH, Zhou Z.

Mod Pathol. 2011 Jul;24(7):899-907. doi: 10.1038/modpathol.2011.47. Epub 2011 Apr 1.

29.

MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.

Feber A, Xi L, Pennathur A, Gooding WE, Bandla S, Wu M, Luketich JD, Godfrey TE, Litle VR.

Ann Thorac Surg. 2011 May;91(5):1523-30. doi: 10.1016/j.athoracsur.2011.01.056. Epub 2011 Mar 21.

30.

Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer.

Ferris RL, Xi L, Seethala RR, Chan J, Desai S, Hoch B, Gooding W, Godfrey TE.

Clin Cancer Res. 2011 Apr 1;17(7):1858-66. doi: 10.1158/1078-0432.CCR-10-3110. Epub 2011 Feb 25.

31.

A quantitative reverse transcription-PCR assay for rapid, automated analysis of breast cancer sentinel lymph nodes.

Hughes SJ, Xi L, Gooding WE, Cole DJ, Mitas M, Metcalf J, Bhargava R, Dabbs D, Ching J, Kozma L, McMillan W, Godfrey TE.

J Mol Diagn. 2009 Nov;11(6):576-82. doi: 10.2353/jmoldx.2009.090037. Epub 2009 Oct 1.

32.

Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.

Gupta VK, Feber A, Xi L, Pennathur A, Wu M, Luketich JD, Godfrey TE.

Clin Cancer Res. 2008 Dec 1;14(23):7804-12. doi: 10.1158/1078-0432.CCR-08-0744.

33.

Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.

Hilari JM, Mangas C, Xi L, Paradelo C, Ferrándiz C, Hughes SJ, Yueh C, Altomare I, Gooding WE, Godfrey TE.

Ann Surg Oncol. 2009 Jan;16(1):177-85. doi: 10.1245/s10434-008-0183-9. Epub 2008 Nov 4.

PMID:
18982394
34.

Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer.

Xi L, Feber A, Gupta V, Wu M, Bergemann AD, Landreneau RJ, Litle VR, Pennathur A, Luketich JD, Godfrey TE.

Nucleic Acids Res. 2008 Nov;36(20):6535-47. doi: 10.1093/nar/gkn697. Epub 2008 Oct 16.

35.

MicroRNA expression profiles of esophageal cancer.

Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR.

J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260. doi: 10.1016/j.jtcvs.2007.08.055. Epub 2007 Dec 26.

36.

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ.

J Mol Diagn. 2007 Nov;9(5):563-71. Epub 2007 Oct 4. Review.

37.
38.

Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma.

Huang X, Godfrey TE, Gooding WE, McCarty KS Jr, Gollin SM.

Genes Chromosomes Cancer. 2006 Nov;45(11):1058-69.

PMID:
16906560
39.

A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients.

Xi L, Coello MC, Litle VR, Raja S, Gooding WE, Yousem SA, El-Hefnawy T, Landreneau RJ, Luketich JD, Godfrey TE.

Clin Cancer Res. 2006 Apr 15;12(8):2484-91.

40.

Identification of mRNA markers for molecular staging of lymph nodes in colorectal cancer.

Xi L, Gooding W, McCarty K, Godfrey TE, Hughes SJ.

Clin Chem. 2006 Mar;52(3):520-3.

41.

A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer.

Hughes SJ, Xi L, Raja S, Gooding W, Cole DJ, Gillanders WE, Mikhitarian K, McCarty K, Silver S, Ching J, McMillan W, Luketich JD, Godfrey TE.

Ann Surg. 2006 Mar;243(3):389-98.

42.

A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetrance.

Khalid A, Finkelstein S, Thompson B, Kelly L, Hanck C, Godfrey TE, Whitcomb DC.

Gut. 2006 May;55(5):728-31. Epub 2005 Dec 14.

43.

Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas.

Xi L, Lyons-Weiler J, Coello MC, Huang X, Gooding WE, Luketich JD, Godfrey TE.

Clin Cancer Res. 2005 Jun 1;11(11):4128-35.

44.

Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer.

Kuss I, Schaefer C, Godfrey TE, Ferris RL, Harris JM, Gooding W, Whiteside TL.

Clin Immunol. 2005 Jul;116(1):27-36.

PMID:
15925829
45.

Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck.

Ferris RL, Xi L, Raja S, Hunt JL, Wang J, Gooding WE, Kelly L, Ching J, Luketich JD, Godfrey TE.

Cancer Res. 2005 Mar 15;65(6):2147-56.

46.

Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing.

Raja S, Ching J, Xi L, Hughes SJ, Chang R, Wong W, McMillan W, Gooding WE, McCarty KS Jr, Chestney M, Luketich JD, Godfrey TE.

Clin Chem. 2005 May;51(5):882-90. Epub 2005 Mar 3.

47.

Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.

Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, Panelli MC, Perricone MA, Petricoin EF, Sauter G, Scheibenbogen C, Shivers SC, Taylor DL, Weinstein JN, Whiteside TL.

J Immunother. 2005 Mar-Apr;28(2):79-119.

PMID:
15725954
48.

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

Herrera LJ, El-Hefnawy T, Queiroz de Oliveira PE, Raja S, Finkelstein S, Gooding W, Luketich JD, Godfrey TE, Hughes SJ.

Neoplasia. 2005 Jan;7(1):75-84.

49.

Molecular staging of lymph nodes from patients with esophageal adenocarcinoma.

Xi L, Luketich JD, Raja S, Gooding WE, Litle VR, Coello MC, Finkelstein SD, Chestney ML, Landreneau RJ, Hughes SJ, Godfrey TE.

Clin Cancer Res. 2005 Feb 1;11(3):1099-109.

50.

Chemokine receptors 6 and 7 identify a metastatic expression pattern in squamous cell carcinoma of the head and neck.

Wang J, Xi L, Gooding W, Godfrey TE, Ferris RL.

Adv Otorhinolaryngol. 2005;62:121-33. Review.

PMID:
15608423

Supplemental Content

Loading ...
Support Center